Association of genetic polymorphisms at IL28B amongst different disease groups and interferon responsiveness in chronic HCV patients from Eastern ...

527 Words2 Pages

Chronic Hepatitis C Virus (HCV) infection is a major cause for developing cirrhosis and hepatocellular carcinoma, with an estimated global prevalence of 3% occurring in about 180 million carriers and approximately 4 million people are being newly infected annually (1). According to WHO, HCV is found worldwide with certain countries having chronic infection rates as high as 5% or above. In India 12.5 million people are infected with HCV (2). This virus is spread primarily by blood to blood contact associated with intravenous drug use, poorly sterilized medical equipment and transfusions (3). The gold standard therapy for chronic hepatitis C (CHC) consists of Pegylated Interferon (Peg-IFN) and ribavirin, but reports show that the drugs are not well tolerated (4). Recent observations on the genetic determinants of CHC established that a single nucleotide polymorphism in the interleukin (IL)-28B gene influences the treatment outcome of the HCV. The genomic region associated with HCV treatment response lies on chromosome 19 and contains multiple SNP’s in linkage disequilibrium around the IL28B gene (5). Some of these variations may result in the altered IL28B gene, which is strongly associated with more than 2 fold difference in the rate of sustained virological response (SVR) in IFN based treatment (4). IL28B rs 12979860 (rs 60) genotype (CC, CT, TT) was the first polymorphism of the IL28B gene to be identified and was associated with two fold improvement amongst European, Hispanic and African –American population. The second polymorphism identified at rs 8099917(rs 17) genotype (TT, TG, GG) was found to be strongly associated in individuals of Australian and northern European ancestry (6).
Different studies have shown that race, ge...

... middle of paper ...

... progression of hepatitis C virus in Moroccan patient. PLoS One. 2013; 8(1):e54793

17. Sivaprasad S, Rao PN, Gupta R, Ashwini K, Reddy DN. The Distribution of
Genotype and Allelic Frequency of IL28B Gene Polymorphism in Andhra
Pradesh, India. J Clin Exp Hepatol 2012; 2(1): 112-115

18. Lutz P, Wasmuth JC, Nischalke HD et al. Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene. Eur J Med Res. 2011; 16(8):335-41

19. Rembeck K, Alsio A, Christensen PB, Farkkila M, Langeland N, et al. Impact of
IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. PLoS One 2012; 7: e29370. (doi:
10.1371/journal.pone.0029370)

More about Association of genetic polymorphisms at IL28B amongst different disease groups and interferon responsiveness in chronic HCV patients from Eastern ...

Open Document